|
US2018200230A1
|
|
Methods of treating neurodegenerative diseases using indane acetic acid derivatives which penetrate the blood brain barrier
|
|
WO2015061481A1
|
|
Methods of treating liquid tumors using compositions comprising spicamycin derivatives
|
|
US2014370011A1
|
|
Methods of treating or preventing cognitive impairment using indane acetic acid derivatives
|
|
US2014086910A1
|
|
Methods of treating or preventing alzheimer's disease using indane acetic acid derivatives
|
|
CA2880853A1
|
|
Compositions comprising spicamycin derivatives and methods of use thereof
|
|
WO2012074980A2
|
|
Methods of treating or preventing autoimmune disorders and liver disorders using indane acetic acid derivatives
|
|
WO2011143522A2
|
|
Enhanced homing and engraftment of hematopoietic stem cells using boroproline compounds
|
|
WO2011143521A2
|
|
Enhanced homing and engraftment of hematopoietic stem cells using cd26 inhibitors
|
|
WO2010141690A2
|
|
Indane analogs and use as pharmaceutical agents and process of making
|
|
WO2010141696A1
|
|
Methods of treating or preventing psoriasis, and/or alzheimer's disease using indane acetic acid derivatives
|
|
CN102202672A
|
|
Methods for treating or preventing pain using spicamycin derivatives
|
|
EP2309859A1
|
|
Enzyme inhibitors and the use thereof
|
|
US2010210695A1
|
|
Compositions and methods for treating skin disorders
|
|
WO2008066729A2
|
|
Boronic acid containing compositions
|
|
WO2007127204A2
|
|
Methods and compositions relating to immunostimulation
|
|
WO2007028145A2
|
|
Agents and methods for reducing protein tyrosine phosphatase 1b activity in the central nervous system
|
